MOUNTAIN VIEW, CA--(Marketwire - June 14, 2011) - Based on its recent analysis of the medical imaging analytics market, Frost & Sullivan recognizes EDDA Technology (EDDA) with the 2011 North American Frost & Sullivan Award for Technology Innovation. Technology innovation is a core cultural value of EDDA, which it has successfully leveraged to pursue best-in-class expertise with multi-modality imaging analytics, while expanding its scope and capabilities to provide complete workflow solutions of computer assisted decision support for radiology and surgery.
"Studies have shown that the death rates of lung and liver disease, some of the highest in the U.S., can be improved effectively through early detection and intervention, making them among the best candidates for meaningful technology innovation," said Frost & Sullivan Principal Analyst Nadim Daher. "EDDA has continually delivered to its customers and OEM partners, breakthrough technology and innovative products, especially in the areas of computer-aided detection (CAD) and decision support for diagnosis and treatment."
Already a top provider of CAD solutions for lung and liver imaging using multiple modalities including multi-detector computed tomography (MDCT), digital radiography (DR), EDDA is further moving into magnetic resonance imaging (MRI) and other clinical applications. In the area of digital X-ray for low dose high performance solutions, EDDA is pioneering the imaging industry's research and development (R&D) efforts towards using CAD for DR Tomosynthesis. EDDA is also leveraging its core competency in real-time quantitative imaging analysis to embark on the R&D of multi-modality intra-operative imaging applications for interventional procedures and surgeries in modern operation suites.
In addition, EDDA has adopted both an organ focus as well as a disease focus to develop a complete portfolio of image analytics solutions going well beyond the traditional CAD functions. EDDA has designed these solutions with an enterprise perspective in mind, as they cater to the needs of not just individual clinical departments, but of the entire, diverse and multi-disciplinary teams that act across the continuum of care.
In the case of liver disease, for example, EDDA's IQQA®-Liver platform coordinates the workflow of multiple stakeholders along the cycle of liver care, including radiologists, interventional radiologists, transplantation and other liver surgeons and oncologists. It is the industry's most comprehensive workflow solution for liver care and is being well received by the marketplace. In fact, the IQQA Enterprise Engine allows integrating EDDA's as well as other third party image analytics applications into virtually any OEM PACS system.
"In essence, EDDA's value proposition is to leverage sophisticated image analytics applications to provide enhanced clinical efficiency and effectiveness in healthcare imaging," said Daher. "Through its clinical depth and enterprise-wide breadth, EDDA's solution set aligns perfectly well with the paradigm shifts taking place in the U.S. healthcare system, as it trends towards more IT workflow-based collaboration between radiologists and their enterprise customers on one hand, and towards a tighter connection between detection, diagnosis, pre-treatment planning as well as post-treatment evaluation follow-up on the other hand."
EDDA fared relatively well through the industry wide slowdown in 2009, which has shown that solutions having such high clinical significance have been least affected by financial austerity measures at the top level of department and hospital budgets. During this period, EDDA continued to grow its direct customer base of hospital facilities, while maintaining a solid OEM business partnering with leading imaging equipment industry vendors including Philips and Shimadzu. In fact, some of these industry partnerships have been taken to the next level of collaborative research and development partnerships. Overall, EDDA is extremely well positioned at the forefront of the next phase facing the industry.
In recognition of these achievements, Frost & Sullivan is proud to present EDDA with the 2011 North American Technology Innovation Award in medical imaging analytics. Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing a technology, which significantly impacts both the functionality and the customer value of new products and applications. The award lauds the relevance of the innovation to the industry.
Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research in order to identify best practices in the industry.
About EDDA Technology
EDDA Technology, Inc. is an innovative clinical computer solution provider in healthcare imaging and analysis. EDDA offers a series of next generation computer assistance solutions to the entire patient care management cycle, including enabling early detection and diagnosis of diseases, as well as enhancing efficiency and precision in treatment planning, management and follow-up. EDDA's goal is to deliver, with broad accessibility, advanced information analysis technologies that improve clinical workflow and accuracy. A privately held Delaware corporation, EDDA is headquartered in Princeton, New Jersey, and has a subsidiary in Shanghai, China. IQQA® is a registered trademark of EDDA Technology. http://www.eddatech.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.awards.frost.com.